MDT

86.81

+0.25%↑

121.23

+2.1%↑

VEEV

167.91

-0.62%↓

HQY

86.23

+2.35%↑

NEOG

9.59

+2.79%↑

MDT

86.81

+0.25%↑

121.23

+2.1%↑

VEEV

167.91

-0.62%↓

HQY

86.23

+2.35%↑

NEOG

9.59

+2.79%↑

MDT

86.81

+0.25%↑

121.23

+2.1%↑

VEEV

167.91

-0.62%↓

HQY

86.23

+2.35%↑

NEOG

9.59

+2.79%↑

MDT

86.81

+0.25%↑

121.23

+2.1%↑

VEEV

167.91

-0.62%↓

HQY

86.23

+2.35%↑

NEOG

9.59

+2.79%↑

MDT

86.81

+0.25%↑

121.23

+2.1%↑

VEEV

167.91

-0.62%↓

HQY

86.23

+2.35%↑

NEOG

9.59

+2.79%↑

Home・Akciju saraksts・10X Genomics Inc (Class A)

10X Genomics Inc (Class A)

Atvērts

SektorsVeselības aprūpe

26.2 4.38

Pirkt Pārdot

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

24.73

Max

26.38

Galvenie mērījumi
By Trading Economics
Ienākumi	11M -16M
Pārdošana	17M 166M
Peļņas marža	-9.789
Darbinieki	1,178
EBITDA	-3.6M -20M

Rekomendācijas
By TipRanks
Rekomendācijas	Pirkt
Prognoze 12 mēnešiem	-16.84% downside

Dividendes
By Dow Jones
Nākamie ieņēmumi	2026. g. 7. maijs

Tirgus statistika
By TradingEconomics
Tirgus kapitalizācija	666M 3B
Iepriekšējā atvēršanas cena	21.82
Iepriekšējā slēgšanas cena	26.2

Ziņu noskaņojums

By Acuity

13%

87%

17 / 348 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Bullish Evidence

8.32 / 8.63 Atbalsts un pretestība

10X Genomics Inc (Class A) Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 16. apr. 23:26 UTC

Karstas akcijas

Stocks to Watch: Netflix, Alcoa, Knight-Swift, NiSource

2026. g. 16. apr. 20:41 UTC

Galvenie tirgus virzītāji

Netflix Shares Slide After 2Q Outlook Misses Wall Street's Expectations

2026. g. 16. apr. 23:49 UTC

Tirgus saruna

Amplitude's Pivot to Oil-Linked Supply Deal Catches Bull's Eye -- Market Talk

2026. g. 16. apr. 23:45 UTC

Tirgus saruna

Nikkei May Decline After Hitting Record High -- Market Talk

2026. g. 16. apr. 23:33 UTC

Tirgus saruna

Galvenie ziņu notikumi

Gold Edges Higher on Hopes for U.S.-Iran Deal -- Market Talk

2026. g. 16. apr. 22:51 UTC

Tirgus saruna

Netflix Sees Signs That Podcasts May Boost Engagement -- Market Talk

2026. g. 16. apr. 22:08 UTC

Peļņas

Netflix Chair Reed Hastings to Leave Board in June -- 3rd Update

2026. g. 16. apr. 22:06 UTC

Peļņas

Lundin Mining: Earnings From Discontinued Ops in 1Q Expected to Be Positively Impacted by Unaudited Gain on Disposal of Eagle Mine, Totaling Approximately $4M >LUN.T

2026. g. 16. apr. 22:06 UTC

Peļņas

Lundin Mining: Pre-Announces Items Impacting 1Q Results

2026. g. 16. apr. 22:06 UTC

Peļņas

Lundin Mining: Items of Significant Impact in 1Q Expected to Include Unaudited Realized Losses on Derivative Contracts of Approximately $13M, Primarily Related to Gold Collar Contracts >LUN.T

2026. g. 16. apr. 22:06 UTC

Peļņas

Lundin Mining: Rev in 1Q Expected to Be Positively Impacted by Unaudited Provisional Pricing Adjustments on Prior-Period Concentrate Sales of Approximately $22M on Pre-Tax Basis >LUN.T

2026. g. 16. apr. 22:06 UTC

Peļņas

Lundin Mining: Adjustments Primarily Include Upward Adjustments in Relation to Prior-Period Metal Sales >LUN.T

2026. g. 16. apr. 20:50 UTC

Tirgus saruna

Peļņas

Tech, Media & Telecom Roundup: Market Talk

2026. g. 16. apr. 20:50 UTC

Tirgus saruna

Financial Services Roundup: Market Talk

2026. g. 16. apr. 20:50 UTC

Tirgus saruna

Galvenie ziņu notikumi

Basic Materials Roundup: Market Talk

2026. g. 16. apr. 20:50 UTC

Tirgus saruna

Peļņas

Health Care Roundup: Market Talk

2026. g. 16. apr. 20:49 UTC

Peļņas

SpaceX Is Ready to Go Public. The Stock Market Is Its Rocket. -- Barrons.com

2026. g. 16. apr. 20:43 UTC

Peļņas

Update: Netflix Stock Falls on Weak Guidance. Founder Reed Hastings Is Leaving the Board. -- Barrons.com

2026. g. 16. apr. 20:40 UTC

Tirgus saruna

Peļņas

Global Equities Roundup: Market Talk

2026. g. 16. apr. 20:40 UTC

Tirgus saruna

Peļņas

Netflix Says Engagement Quality Hits New High -- Market Talk

2026. g. 16. apr. 20:30 UTC

Karstas akcijas

Stocks to Watch: TSMC, Abbott Laboratories, Nvidia, Netflix -- WSJ

2026. g. 16. apr. 20:25 UTC

Peļņas

Netflix Stock Falls on Weak Guidance. Founder Reed Hastings Is Leaving the Board. -- Barrons.com

2026. g. 16. apr. 20:23 UTC

Peļņas

These Stocks Are Today's Movers: AMD, Intel, TSMC, Abbott, Hims, Corning, Schwab, Polaris, and More -- Barrons.com

2026. g. 16. apr. 20:19 UTC

Peļņas

Netflix Guidance Disappoints. The Stock Is Down. -- Barrons.com

2026. g. 16. apr. 20:17 UTC

Peļņas

Alcoa: Alumina Costs in the Aluminum Segment Are Expected to Be Favorable by Approximately $20M Sequentially >AA

2026. g. 16. apr. 20:17 UTC

Peļņas

Alcoa: Based on Higher LME and Midwest Premium Pricing and Expected Higher Shipments, Section 232 Tariff Costs on U.S. Imports of Aluminum From Canada Expected to Increase $35M Sequentially >AA

2026. g. 16. apr. 20:16 UTC

Peļņas

Alcoa: Expects 2026 Total Aluminum Segment Production and Shipments Ranging Between 2.4M and 2.6M Metric Tons, and Between 2.6M and 2.8M Metric Tons, Respectively >AA

2026. g. 16. apr. 20:16 UTC

Peļņas

Alcoa: Expects 2026 Total Aluminum Segment Production and Shipments to Remain Unchanged From Its Prior Projection >AA

2026. g. 16. apr. 20:16 UTC

Peļņas

Alcoa: Expects 2026 Total Alumina Segment Production and Shipments Ranging Between 9.7M to 9.9M Metric Tons, and Between 11.8M and 12.0M Metric Tons, Respectively >AA

2026. g. 16. apr. 20:16 UTC

Peļņas

Alcoa: Expects 2026 Total Alumina Segment Production and Shipments to Remain Unchanged From Prior Projection >AA

Salīdzinājums

Cenas izmaiņa

10X Genomics Inc (Class A) Prognoze

Cenas mērķis

By TipRanks

-16.84% uz leju

Prognoze 12 mēnešiem

Vidējais 21.08 USD -16.84%

Augstākais 30 USD

Zemākais 17 USD

Pamatojoties uz 13 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi 10X Genomics Inc (Class A) — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

13 ratings

Pirkt

Turēt

Pārdot

Pamatojoties uz 13 analītiķiem, kas pēdējo 3 mēnešu laikā snieguši akciju vērtējumus instrumentam 10X Genomics Inc (Class A) — pēdējo 3 mēnešu laikā.

Tehniskais rādītājs

By Trading Central

8.32 / 8.63Atbalsts un pretestība

Recent bullish events outweigh bearish events.

There are no events.

Noskaņojums

By Acuity

17 / 348 Rangs Veselības aprūpe

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

Par 10X Genomics Inc (Class A)

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.